Landscapes / Companies

argenx not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved
Next date
Empasiprubart, Phase 2 trial completes
Drugs
6
in active trials · 9 in all
Trials
35 active
73 since 2021

Drugs6

DrugHow it worksPartnerStageNext dateDetails
—
Approved Mar 2027Phase 2/3 trial completes
Artificial immunoglobulin
Phase 3 Nov 2026soonPhase 2 trial completes
Artificial immunoglobulin
Phase 3 28 May 2029Phase 2 trial completes
EFG PH20not checked
—
Phase 2 Mar 2027Phase 2 trial completes
—
Phase 2 29 Oct 2029Phase 2 trial completes
—
Phase 1 31 Dec 2026Phase 1 trial completes

About

No active trial
ARGX-109, ARGX-213, efgartigimod PH20 in stage B
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Argenx

Following is part of Solo: you see every change to Argenx the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in